Global Embolization Particle Market Analysis and Forecast 2024-2030
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
According to APO Research, The global Embolization Particle market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.
This report presents an overview of global market for Embolization Particle, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Embolization Particle, also provides the sales of main regions and countries. Of the upcoming market potential for Embolization Particle, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Embolization Particle sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Embolization Particle market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Embolization Particle sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials B.V. and Alicon, etc.
Embolization Particle segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Embolization Particle market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Embolization Particle and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Embolization Particle.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Embolization Particle in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Embolization Particle sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
According to APO Research, The global Embolization Particle market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.
This report presents an overview of global market for Embolization Particle, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Embolization Particle, also provides the sales of main regions and countries. Of the upcoming market potential for Embolization Particle, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Embolization Particle sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Embolization Particle market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Embolization Particle sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials B.V. and Alicon, etc.
Embolization Particle segment by Company
- Sirtex Medical
- Merit Medical
- Cook Medical
- BTG Medical
- Boston Scientific Corporation
- Terumo Corporation
- HENGRUI Medical
- INterface BIOmaterials B.V.
- Alicon
- Microspheres
- Particles (e.g. PVA Particles, Gelfoam Particles)
- Drug-eluting Beads (DEBs)
- Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
- Uterine Fibroid Embolization
- Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
- Liver Tumor Embolization
- Trauma Embolization
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Embolization Particle market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Embolization Particle and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Embolization Particle.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Embolization Particle in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Embolization Particle sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Embolization Particle Market by Type
1.2.1 Global Embolization Particle Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Microspheres
1.2.3 Particles (e.g. PVA Particles, Gelfoam Particles)
1.2.4 Drug-eluting Beads (DEBs)
1.2.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.3 Embolization Particle Market by Application
1.3.1 Global Embolization Particle Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Uterine Fibroid Embolization
1.3.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.3.4 Liver Tumor Embolization
1.3.5 Trauma Embolization
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 EMBOLIZATION PARTICLE MARKET DYNAMICS
2.1 Embolization Particle Industry Trends
2.2 Embolization Particle Industry Drivers
2.3 Embolization Particle Industry Opportunities and Challenges
2.4 Embolization Particle Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Embolization Particle Revenue Estimates and Forecasts (2019-2030)
3.2 Global Embolization Particle Revenue by Region
3.2.1 Global Embolization Particle Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Embolization Particle Revenue by Region (2019-2024)
3.2.3 Global Embolization Particle Revenue by Region (2025-2030)
3.2.4 Global Embolization Particle Revenue Market Share by Region (2019-2030)
3.3 Global Embolization Particle Sales Estimates and Forecasts 2019-2030
3.4 Global Embolization Particle Sales by Region
3.4.1 Global Embolization Particle Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Embolization Particle Sales by Region (2019-2024)
3.4.3 Global Embolization Particle Sales by Region (2025-2030)
3.4.4 Global Embolization Particle Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Embolization Particle Revenue by Manufacturers
4.1.1 Global Embolization Particle Revenue by Manufacturers (2019-2024)
4.1.2 Global Embolization Particle Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Embolization Particle Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Embolization Particle Sales by Manufacturers
4.2.1 Global Embolization Particle Sales by Manufacturers (2019-2024)
4.2.2 Global Embolization Particle Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Embolization Particle Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Embolization Particle Sales Price by Manufacturers (2019-2024)
4.4 Global Embolization Particle Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Embolization Particle Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Embolization Particle Manufacturers, Product Type & Application
4.7 Global Embolization Particle Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Embolization Particle Market CR5 and HHI
4.8.2 2023 Embolization Particle Tier 1, Tier 2, and Tier
5 EMBOLIZATION PARTICLE MARKET BY TYPE
5.1 Global Embolization Particle Revenue by Type
5.1.1 Global Embolization Particle Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Embolization Particle Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Embolization Particle Revenue Market Share by Type (2019-2030)
5.2 Global Embolization Particle Sales by Type
5.2.1 Global Embolization Particle Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Embolization Particle Sales by Type (2019-2030) & (K Units)
5.2.3 Global Embolization Particle Sales Market Share by Type (2019-2030)
5.3 Global Embolization Particle Price by Type
6 EMBOLIZATION PARTICLE MARKET BY APPLICATION
6.1 Global Embolization Particle Revenue by Application
6.1.1 Global Embolization Particle Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Embolization Particle Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Embolization Particle Revenue Market Share by Application (2019-2030)
6.2 Global Embolization Particle Sales by Application
6.2.1 Global Embolization Particle Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Embolization Particle Sales by Application (2019-2030) & (K Units)
6.2.3 Global Embolization Particle Sales Market Share by Application (2019-2030)
6.3 Global Embolization Particle Price by Application
7 COMPANY PROFILES
7.1 Sirtex Medical
7.1.1 Sirtex Medical Comapny Information
7.1.2 Sirtex Medical Business Overview
7.1.3 Sirtex Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Sirtex Medical Embolization Particle Product Portfolio
7.1.5 Sirtex Medical Recent Developments
7.2 Merit Medical
7.2.1 Merit Medical Comapny Information
7.2.2 Merit Medical Business Overview
7.2.3 Merit Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Merit Medical Embolization Particle Product Portfolio
7.2.5 Merit Medical Recent Developments
7.3 Cook Medical
7.3.1 Cook Medical Comapny Information
7.3.2 Cook Medical Business Overview
7.3.3 Cook Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Cook Medical Embolization Particle Product Portfolio
7.3.5 Cook Medical Recent Developments
7.4 BTG Medical
7.4.1 BTG Medical Comapny Information
7.4.2 BTG Medical Business Overview
7.4.3 BTG Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 BTG Medical Embolization Particle Product Portfolio
7.4.5 BTG Medical Recent Developments
7.5 Boston Scientific Corporation
7.5.1 Boston Scientific Corporation Comapny Information
7.5.2 Boston Scientific Corporation Business Overview
7.5.3 Boston Scientific Corporation Embolization Particle Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Boston Scientific Corporation Embolization Particle Product Portfolio
7.5.5 Boston Scientific Corporation Recent Developments
7.6 Terumo Corporation
7.6.1 Terumo Corporation Comapny Information
7.6.2 Terumo Corporation Business Overview
7.6.3 Terumo Corporation Embolization Particle Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Terumo Corporation Embolization Particle Product Portfolio
7.6.5 Terumo Corporation Recent Developments
7.7 HENGRUI Medical
7.7.1 HENGRUI Medical Comapny Information
7.7.2 HENGRUI Medical Business Overview
7.7.3 HENGRUI Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 HENGRUI Medical Embolization Particle Product Portfolio
7.7.5 HENGRUI Medical Recent Developments
7.8 INterface BIOmaterials B.V.
7.8.1 INterface BIOmaterials B.V. Comapny Information
7.8.2 INterface BIOmaterials B.V. Business Overview
7.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 INterface BIOmaterials B.V. Embolization Particle Product Portfolio
7.8.5 INterface BIOmaterials B.V. Recent Developments
7.9 Alicon
7.9.1 Alicon Comapny Information
7.9.2 Alicon Business Overview
7.9.3 Alicon Embolization Particle Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Alicon Embolization Particle Product Portfolio
7.9.5 Alicon Recent Developments
8 NORTH AMERICA
8.1 North America Embolization Particle Market Size by Type
8.1.1 North America Embolization Particle Revenue by Type (2019-2030)
8.1.2 North America Embolization Particle Sales by Type (2019-2030)
8.1.3 North America Embolization Particle Price by Type (2019-2030)
8.2 North America Embolization Particle Market Size by Application
8.2.1 North America Embolization Particle Revenue by Application (2019-2030)
8.2.2 North America Embolization Particle Sales by Application (2019-2030)
8.2.3 North America Embolization Particle Price by Application (2019-2030)
8.3 North America Embolization Particle Market Size by Country
8.3.1 North America Embolization Particle Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Embolization Particle Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Embolization Particle Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Embolization Particle Market Size by Type
9.1.1 Europe Embolization Particle Revenue by Type (2019-2030)
9.1.2 Europe Embolization Particle Sales by Type (2019-2030)
9.1.3 Europe Embolization Particle Price by Type (2019-2030)
9.2 Europe Embolization Particle Market Size by Application
9.2.1 Europe Embolization Particle Revenue by Application (2019-2030)
9.2.2 Europe Embolization Particle Sales by Application (2019-2030)
9.2.3 Europe Embolization Particle Price by Application (2019-2030)
9.3 Europe Embolization Particle Market Size by Country
9.3.1 Europe Embolization Particle Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Embolization Particle Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Embolization Particle Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Embolization Particle Market Size by Type
10.1.1 China Embolization Particle Revenue by Type (2019-2030)
10.1.2 China Embolization Particle Sales by Type (2019-2030)
10.1.3 China Embolization Particle Price by Type (2019-2030)
10.2 China Embolization Particle Market Size by Application
10.2.1 China Embolization Particle Revenue by Application (2019-2030)
10.2.2 China Embolization Particle Sales by Application (2019-2030)
10.2.3 China Embolization Particle Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Embolization Particle Market Size by Type
11.1.1 Asia Embolization Particle Revenue by Type (2019-2030)
11.1.2 Asia Embolization Particle Sales by Type (2019-2030)
11.1.3 Asia Embolization Particle Price by Type (2019-2030)
11.2 Asia Embolization Particle Market Size by Application
11.2.1 Asia Embolization Particle Revenue by Application (2019-2030)
11.2.2 Asia Embolization Particle Sales by Application (2019-2030)
11.2.3 Asia Embolization Particle Price by Application (2019-2030)
11.3 Asia Embolization Particle Market Size by Country
11.3.1 Asia Embolization Particle Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Embolization Particle Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Embolization Particle Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Embolization Particle Market Size by Type
12.1.1 MEALA Embolization Particle Revenue by Type (2019-2030)
12.1.2 MEALA Embolization Particle Sales by Type (2019-2030)
12.1.3 MEALA Embolization Particle Price by Type (2019-2030)
12.2 MEALA Embolization Particle Market Size by Application
12.2.1 MEALA Embolization Particle Revenue by Application (2019-2030)
12.2.2 MEALA Embolization Particle Sales by Application (2019-2030)
12.2.3 MEALA Embolization Particle Price by Application (2019-2030)
12.3 MEALA Embolization Particle Market Size by Country
12.3.1 MEALA Embolization Particle Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Embolization Particle Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Embolization Particle Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Embolization Particle Value Chain Analysis
13.1.1 Embolization Particle Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Embolization Particle Production Mode & Process
13.2 Embolization Particle Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Embolization Particle Distributors
13.2.3 Embolization Particle Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Embolization Particle Market by Type
1.2.1 Global Embolization Particle Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Microspheres
1.2.3 Particles (e.g. PVA Particles, Gelfoam Particles)
1.2.4 Drug-eluting Beads (DEBs)
1.2.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.3 Embolization Particle Market by Application
1.3.1 Global Embolization Particle Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Uterine Fibroid Embolization
1.3.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.3.4 Liver Tumor Embolization
1.3.5 Trauma Embolization
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 EMBOLIZATION PARTICLE MARKET DYNAMICS
2.1 Embolization Particle Industry Trends
2.2 Embolization Particle Industry Drivers
2.3 Embolization Particle Industry Opportunities and Challenges
2.4 Embolization Particle Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Embolization Particle Revenue Estimates and Forecasts (2019-2030)
3.2 Global Embolization Particle Revenue by Region
3.2.1 Global Embolization Particle Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Embolization Particle Revenue by Region (2019-2024)
3.2.3 Global Embolization Particle Revenue by Region (2025-2030)
3.2.4 Global Embolization Particle Revenue Market Share by Region (2019-2030)
3.3 Global Embolization Particle Sales Estimates and Forecasts 2019-2030
3.4 Global Embolization Particle Sales by Region
3.4.1 Global Embolization Particle Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Embolization Particle Sales by Region (2019-2024)
3.4.3 Global Embolization Particle Sales by Region (2025-2030)
3.4.4 Global Embolization Particle Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Embolization Particle Revenue by Manufacturers
4.1.1 Global Embolization Particle Revenue by Manufacturers (2019-2024)
4.1.2 Global Embolization Particle Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Embolization Particle Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Embolization Particle Sales by Manufacturers
4.2.1 Global Embolization Particle Sales by Manufacturers (2019-2024)
4.2.2 Global Embolization Particle Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Embolization Particle Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Embolization Particle Sales Price by Manufacturers (2019-2024)
4.4 Global Embolization Particle Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Embolization Particle Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Embolization Particle Manufacturers, Product Type & Application
4.7 Global Embolization Particle Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Embolization Particle Market CR5 and HHI
4.8.2 2023 Embolization Particle Tier 1, Tier 2, and Tier
5 EMBOLIZATION PARTICLE MARKET BY TYPE
5.1 Global Embolization Particle Revenue by Type
5.1.1 Global Embolization Particle Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Embolization Particle Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Embolization Particle Revenue Market Share by Type (2019-2030)
5.2 Global Embolization Particle Sales by Type
5.2.1 Global Embolization Particle Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Embolization Particle Sales by Type (2019-2030) & (K Units)
5.2.3 Global Embolization Particle Sales Market Share by Type (2019-2030)
5.3 Global Embolization Particle Price by Type
6 EMBOLIZATION PARTICLE MARKET BY APPLICATION
6.1 Global Embolization Particle Revenue by Application
6.1.1 Global Embolization Particle Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Embolization Particle Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Embolization Particle Revenue Market Share by Application (2019-2030)
6.2 Global Embolization Particle Sales by Application
6.2.1 Global Embolization Particle Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Embolization Particle Sales by Application (2019-2030) & (K Units)
6.2.3 Global Embolization Particle Sales Market Share by Application (2019-2030)
6.3 Global Embolization Particle Price by Application
7 COMPANY PROFILES
7.1 Sirtex Medical
7.1.1 Sirtex Medical Comapny Information
7.1.2 Sirtex Medical Business Overview
7.1.3 Sirtex Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Sirtex Medical Embolization Particle Product Portfolio
7.1.5 Sirtex Medical Recent Developments
7.2 Merit Medical
7.2.1 Merit Medical Comapny Information
7.2.2 Merit Medical Business Overview
7.2.3 Merit Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Merit Medical Embolization Particle Product Portfolio
7.2.5 Merit Medical Recent Developments
7.3 Cook Medical
7.3.1 Cook Medical Comapny Information
7.3.2 Cook Medical Business Overview
7.3.3 Cook Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Cook Medical Embolization Particle Product Portfolio
7.3.5 Cook Medical Recent Developments
7.4 BTG Medical
7.4.1 BTG Medical Comapny Information
7.4.2 BTG Medical Business Overview
7.4.3 BTG Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 BTG Medical Embolization Particle Product Portfolio
7.4.5 BTG Medical Recent Developments
7.5 Boston Scientific Corporation
7.5.1 Boston Scientific Corporation Comapny Information
7.5.2 Boston Scientific Corporation Business Overview
7.5.3 Boston Scientific Corporation Embolization Particle Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Boston Scientific Corporation Embolization Particle Product Portfolio
7.5.5 Boston Scientific Corporation Recent Developments
7.6 Terumo Corporation
7.6.1 Terumo Corporation Comapny Information
7.6.2 Terumo Corporation Business Overview
7.6.3 Terumo Corporation Embolization Particle Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Terumo Corporation Embolization Particle Product Portfolio
7.6.5 Terumo Corporation Recent Developments
7.7 HENGRUI Medical
7.7.1 HENGRUI Medical Comapny Information
7.7.2 HENGRUI Medical Business Overview
7.7.3 HENGRUI Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 HENGRUI Medical Embolization Particle Product Portfolio
7.7.5 HENGRUI Medical Recent Developments
7.8 INterface BIOmaterials B.V.
7.8.1 INterface BIOmaterials B.V. Comapny Information
7.8.2 INterface BIOmaterials B.V. Business Overview
7.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 INterface BIOmaterials B.V. Embolization Particle Product Portfolio
7.8.5 INterface BIOmaterials B.V. Recent Developments
7.9 Alicon
7.9.1 Alicon Comapny Information
7.9.2 Alicon Business Overview
7.9.3 Alicon Embolization Particle Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Alicon Embolization Particle Product Portfolio
7.9.5 Alicon Recent Developments
8 NORTH AMERICA
8.1 North America Embolization Particle Market Size by Type
8.1.1 North America Embolization Particle Revenue by Type (2019-2030)
8.1.2 North America Embolization Particle Sales by Type (2019-2030)
8.1.3 North America Embolization Particle Price by Type (2019-2030)
8.2 North America Embolization Particle Market Size by Application
8.2.1 North America Embolization Particle Revenue by Application (2019-2030)
8.2.2 North America Embolization Particle Sales by Application (2019-2030)
8.2.3 North America Embolization Particle Price by Application (2019-2030)
8.3 North America Embolization Particle Market Size by Country
8.3.1 North America Embolization Particle Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Embolization Particle Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Embolization Particle Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Embolization Particle Market Size by Type
9.1.1 Europe Embolization Particle Revenue by Type (2019-2030)
9.1.2 Europe Embolization Particle Sales by Type (2019-2030)
9.1.3 Europe Embolization Particle Price by Type (2019-2030)
9.2 Europe Embolization Particle Market Size by Application
9.2.1 Europe Embolization Particle Revenue by Application (2019-2030)
9.2.2 Europe Embolization Particle Sales by Application (2019-2030)
9.2.3 Europe Embolization Particle Price by Application (2019-2030)
9.3 Europe Embolization Particle Market Size by Country
9.3.1 Europe Embolization Particle Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Embolization Particle Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Embolization Particle Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Embolization Particle Market Size by Type
10.1.1 China Embolization Particle Revenue by Type (2019-2030)
10.1.2 China Embolization Particle Sales by Type (2019-2030)
10.1.3 China Embolization Particle Price by Type (2019-2030)
10.2 China Embolization Particle Market Size by Application
10.2.1 China Embolization Particle Revenue by Application (2019-2030)
10.2.2 China Embolization Particle Sales by Application (2019-2030)
10.2.3 China Embolization Particle Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Embolization Particle Market Size by Type
11.1.1 Asia Embolization Particle Revenue by Type (2019-2030)
11.1.2 Asia Embolization Particle Sales by Type (2019-2030)
11.1.3 Asia Embolization Particle Price by Type (2019-2030)
11.2 Asia Embolization Particle Market Size by Application
11.2.1 Asia Embolization Particle Revenue by Application (2019-2030)
11.2.2 Asia Embolization Particle Sales by Application (2019-2030)
11.2.3 Asia Embolization Particle Price by Application (2019-2030)
11.3 Asia Embolization Particle Market Size by Country
11.3.1 Asia Embolization Particle Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Embolization Particle Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Embolization Particle Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Embolization Particle Market Size by Type
12.1.1 MEALA Embolization Particle Revenue by Type (2019-2030)
12.1.2 MEALA Embolization Particle Sales by Type (2019-2030)
12.1.3 MEALA Embolization Particle Price by Type (2019-2030)
12.2 MEALA Embolization Particle Market Size by Application
12.2.1 MEALA Embolization Particle Revenue by Application (2019-2030)
12.2.2 MEALA Embolization Particle Sales by Application (2019-2030)
12.2.3 MEALA Embolization Particle Price by Application (2019-2030)
12.3 MEALA Embolization Particle Market Size by Country
12.3.1 MEALA Embolization Particle Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Embolization Particle Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Embolization Particle Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Embolization Particle Value Chain Analysis
13.1.1 Embolization Particle Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Embolization Particle Production Mode & Process
13.2 Embolization Particle Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Embolization Particle Distributors
13.2.3 Embolization Particle Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
